@article{ATM28754,
author = {Arnaud Bruneel and François Fenaille},
title = {Integrating mass spectrometry-based plasma (or serum) protein N-glycan profiling into the clinical practice?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 6},
year = {2019},
keywords = {},
abstract = {Congenital disorders of glycosylation (CDG) are clinically diverse inherited diseases affecting in particular the glycosylation of proteins. Since the first clinical description of CDGs in 1980 (1), a significant number of new CDG types have been reported with more than 130 today described (2). CDGs are rare essentially autosomal recessive disorders, with about 60% of them affecting protein N-glycosylation (3).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/28754}
}